Overview
Suppurative lymphadenitis is an inflammatory condition characterized by the formation of pus within lymph nodes, often associated with bacterial infections, including those linked to BCG vaccine administration 1.Diagnosis
Clinical presentation includes localized swelling, tenderness, and warmth in the affected lymph node region 1.
Suppurative lymphadenitis is diagnosed definitively through aspiration or excision biopsy revealing purulent material 1.
Imaging (ultrasound) may help in assessing the extent and characteristics of lymphadenopathy 1.Management
First-line treatment: Intramuscular or intravenous antibiotics targeting common pathogens (e.g., Staphylococcus aureus), such as clindamycin or vancomycin, depending on sensitivity profiles 1.
Adjunctive measures: Drainage of fluctuant lymph nodes may be necessary for abscess management 1.
Supportive care: Includes monitoring for systemic infection and ensuring adequate hydration and nutrition 1.Special Populations
Pediatrics: Increased vigilance and prompt intervention are crucial due to the higher incidence observed in vaccinated children 1.
Comorbidities: No specific recommendations provided in the abstract; however, underlying conditions may necessitate tailored antibiotic choices based on susceptibility data 1.Key Recommendations
Active surveillance and reporting systems should be maintained to monitor outbreaks associated with BCG vaccination to facilitate early intervention 1 (Evidence: Moderate).
Prompt aspiration or surgical drainage of suppurative lymph nodes is recommended to prevent complications 1 (Evidence: Moderate).
Antibiotic therapy targeting common pathogens should be initiated based on local resistance patterns and clinical response 1 (Evidence: Moderate).References
1 Soh SB, Han PY, Tam KT, Yung CF, Liew WK, Tan NW et al.. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore. Vaccine 2014. link